ConductScience.org, home

Trial · NCT07894965

Dual-Task Core Stabilization Training in Chronic Nonspecific Low Back Pain

NCT07894965, Not applicable, Not yet recruiting, Karabuk University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Dual-Task Core Stabilization Training in Chronic Nonspecific Low Back Pain. Trials, record NCT07894965. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07894965

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Dual-Task Core Stabilization Training in Chronic Nonspecific Low Back Pain
NCT number
NCT07894965
Status
Not yet recruiting
Phases
Not applicable
Enrollment
90 participants, estimated
Lead sponsor
Karabuk University
Conditions
Chronic Nonspecific Low Back Pain
Interventions
Dual-Task Core Stabilization Exercise, Single-Task Core Stabilization Exercise
First posted
2026-10-26
Last updated
2026-11-03

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryMotor Dual-Task Cost During the Timed Up and Go TestBaseline and post-intervention (approximately 6 weeks)
Motor dual-task cost will be calculated as \[(dual-task TUG time - single-task TUG time) / single-task TUG time\] × 100. TUG time will be measured in seconds. During the dual-task condition, participants will count backward by threes while performing the TUG test. Two trials per condition will be averaged. Higher percentages indicate greater deterioration in motor performance under dual-task conditions. The primary comparison will be the post-intervention value adjusted for baseline performance and age stratum.
SecondaryCognitive Dual-Task Cost During the Timed Up and Go TestBaseline, post-intervention (approximately 6 weeks), and 12-week follow-up.
Cognitive performance will be assessed by counting backward by threes under seated single-task and walking dual-task conditions. The correct response rate will be calculated as correct responses per second. Cognitive dual-task cost (%) = \[(single-task correct response rate - dual-task correct response rate) / single-task correct response rate\] × 100. Higher values indicate greater cognitive performance deterioration.
SecondaryWalking Speed During the 10-Meter Walk TestBaseline, post-intervention (approximately 6 weeks), and 12-week follow-up.
Walking speed will be assessed under single-task and cognitive dual-task conditions on a 14-meter walkway, with the central 10 meters timed. During the dual-task condition, participants will count backward by threes. Two trials per condition will be averaged. Walking speed will be expressed in meters per second (m/s), with higher values indicating faster walking.
SecondarySingle-Leg Stance Test PerformanceBaseline, post-intervention (approximately 6 weeks), and 12-week follow-up.
Static balance will be assessed on the preferred leg with arms crossed over the chest under three conditions: eyes open, eyes open with serial subtraction by threes, and eyes closed. Each trial will be limited to 45 seconds. The better result of two trials will be recorded for each condition. Performance will be expressed in seconds, with longer duration indicating better balance.
SecondaryPain Intensity Measured by the Numerical Rating ScaleBaseline, post-intervention (approximately 6 weeks), and 12-week follow-up.
Average low back pain intensity during the previous week will be assessed using an 11-point Numerical Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity. A reduction of at least 2 points or 30% will be considered clinically important.
SecondaryDisability Measured by the Oswestry Disability IndexBaseline, post-intervention (approximately 6 weeks), and 12-week follow-up.
Low back pain-related disability will be assessed using the validated Turkish version of the Oswestry Disability Index (ODI). Scores will be expressed as percentages from 0% (no disability) to 100% (maximum disability). Higher scores indicate greater disability.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests1

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed as
Arithmetic Fluency TaskSecondary outcome

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07894965

GET https://conductscience.org/api/trials/v1/NCT07894965/registered